Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

FDA approves 1st new class of opioid-free painkillers in over 20 years

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

LiveScience

FDA approves 'ketamine' nasal spray for depression — here's everything you need to know

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with severe depression, the FDA says. Here's what that means.

LiveScience

Chocolate recall elevated to highest risk level by FDA due to risk of 'adverse health consequences’

Three products from Cal Yee Farm’s recall last month are now a ‘Class 1’ level

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Exploring bacopa: the science behind the latest brain health trend

As I’ve grown older and experienced the vagaries of my ageing memory, I’ve often reflected on the possibility of a miracle cure that would rejuvenate it. As if in answer to my wishful thinking, not one but several reports recently appeared simultaneously in the scientific news, highlighting a trending solution…

The Conversation

FDA approves new type of non-opioid pain medication in two decades

The new drug will be many times more expensive than a standard opioid option

The Independent UK

The Just FDA Banned Red No. 3 Dye. What Took It So Long?

Over 35 years after the first study linking Red 3 to thyroid cancer in rats was published, the US is beginning to wean it out of foods and drugs.

Inverse

Trump will change the face of US food policy. These are the players to watch

The industry ties and policy backgrounds of these officials and cabinet nominees are varied – and often contradictory

The Guardian - US

Read news from The Economist, FT, and more,
with one subscription

Journavx, New Type Of Non-Opioid Pain Relief Drug Gets FDA Approval

Suzetrigine, a new non-opioid pain relief drug sold under the brand name Journavx marks the first new class of pain reliever to receive FDA approval in over two decades.

Medical Daily

FDA approves new painkiller that shows promise and challenges of opioid alternatives

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids

The Independent UK

"MAHA" isn't sold on lab-grown meats

"The cultivated meat industry hopes a pro-business argument can win over skeptical Republicans"

Salon

Is Tonix Pharmaceuticals the Next Biotech Breakout?

Tonix Pharmaceuticals' innovative approach to fibromyalgia treatment positions the company for substantial market disruption and long-term growth.

MarketBeat

Chocolate Recall Hits Highest Risk Level Due To Undeclared Milk

A major chocolate recall has been upgraded due to undeclared milk posing serious health risks for allergy sufferers.

Mic

Stricter abortion laws may cause increased infant deaths − 2 maternal and child health researchers explain the data

Infant mortality in the U.S. has increased by 7% since the 2022 Dobbs v. Jackson U.S. Supreme Court decision overturned the constitutional right to abortion, according to an October 2024 study.

The Conversation

Takeaways from RFK Jr.'s first confirmation hearing as Trump's nominee for health secretary

Robert F

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

RFK Jr could soon lead the HHS. Here are the different health agencies it oversees

The member of the Kennedy dynasty has promised to significantly change how the department he could soon lead functions

Top News

HHS Oversees 13 Agencies, Including CDC And FDA

Learn about the US Department of Health and Human Services and its critical role in promoting public health, advancing medical research, and ensuring acces...

International Business Times

Lay's Classic Potato Chips Recall Upgraded To 'Class I' By FDA Due To Milk Allergen

According to the FDA, "Class I" level recalls are used when there is "reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death."

The Times of India

This country approves Ozempic to reduce risk of kidney disease in diabetes patients

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients with chronic kidney disease (CKD).

Latin Times

Caroline Kennedy Slams 'Predator' Cousin RFK Jr. Ahead of Confirmation Hearing: 'No Surprise He Keeps Birds of Prey as Pets'

Caroline Kennedy condemns cousin RFK Jr. as a "predator" before his Senate confirmation for HHS, citing his controversial vaccine views, ethical lapses, history of drug addiction, and exploitation of family tragedies.

The Times of India

Lay's potato chips recall in two USA states; FDA assigns most severe risk warning

Lay's Classic Potato Chips have been recalled in Oregon and Washington after undeclared milk, a major allergen, was found in over 6,000 bags. While FDA implemented this recall last month on December 13, it was classified as 'highest risk level' on January 27.

Reason

Trump Rolls Back FDA Menthol Ban

Biden's FDA pushed a prohibition that disproportionately targeted marginalized communities. Trump's reversal may mark a shift toward smarter drug policy.

Barchart

Citi Analysts Think This Robotic AI Stock Can Surge Another 25% From Here

This robotic AI stock is a “buy and hold” stock for the long term despite its lofty valuation.

1 … 53 54 55 56

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Food and Drug Administration

Department of Health and Human Services

73 stories

FritoLay

63 stories

the Department of Agriculture

56 stories

Vertex Pharmaceuticals

56 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.